Abstract
The study aims to investigate the role of anticoagulation (AC) with either warfarin or rivaroxaban in stroke prevention among patients with atrial fibrillation (AF) who underwent transcatheter aortic valve replacement (TAVR). AF patients who had TAVR at a single center between 2012 and 2015 with at
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have